Healthcare Resource Utilization and Medical Costs in Patients with Ulcerative Colitis Based on Therapy Response to Advanced Therapy: A Descriptive Analysis of German Healthcare Claims Data
Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes significant morbidity and impaired quality of life [ref:1]. In Germany, approximately 5.3 per 1,000 adults are affected [ref:2]. Recent studies showed that most adult patients initiating advanced [for full text, please go to the a.m. URL]
Institutions
- Goethe University Frankfurt (DE)
- Pfizer (Germany) (DE)
- University Hospital Frankfurt (DE)
- Agaplesion Markus Hospital (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2025-11-03
- DOI
- https://doi.org/10.3205/25gmds159
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00